171 related articles for article (PubMed ID: 2533949)
1. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
Nishino Y; Schneider MR; Michna H; el Etreby MF
J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
Zaccheo T; Giudici D; Ornati G; Panzeri A; di Salle E
Eur J Cancer; 1991; 27(9):1145-50. PubMed ID: 1835626
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
Tanaka M; Yano S; Hasegawa Y; Nakao K
Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R
Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
[TBL] [Abstract][Full Text] [Related]
5. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo.
Schieweck K; Bhatnagar AS; Matter A
Cancer Res; 1988 Feb; 48(4):834-8. PubMed ID: 2962734
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.
Schieweck K; Bhatnagar AS; Batzl C; Lang M
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):633-6. PubMed ID: 8476774
[TBL] [Abstract][Full Text] [Related]
8. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
Abul-Hajj YJ
J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585
[TBL] [Abstract][Full Text] [Related]
9. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.
Bhatnagar AS; Häusler A; Schieweck K; Lang M; Bowman R
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1021-7. PubMed ID: 2149502
[TBL] [Abstract][Full Text] [Related]
10. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
Zaccheo T; Giudici D; Lombardi P; di Salle E
Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
[TBL] [Abstract][Full Text] [Related]
11. A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
Tekmal RR; Durgam VR
Cancer Lett; 1997 Sep; 118(1):21-8. PubMed ID: 9310256
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.
Houjou T; Wada T; Yasutomi M
Clin Ther; 1993; 15(1):137-47. PubMed ID: 8458043
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
[TBL] [Abstract][Full Text] [Related]
14. Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
el Etreby MF
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):565-72. PubMed ID: 7682838
[TBL] [Abstract][Full Text] [Related]
15. Novel aromatase inhibitors.
Bhatnagar AS; Häusler A; Schieweck K; Browne LJ; Bowman R; Steele RE
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):363-7. PubMed ID: 2147860
[TBL] [Abstract][Full Text] [Related]
16. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
Tominaga T; Yoshida Y; Shimozuma K; Hayashi K; Kosaki G
Eur J Cancer; 1990; 26(5):600-3. PubMed ID: 2144748
[TBL] [Abstract][Full Text] [Related]
17. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
Zaccheo T; Di Salle E
Cancer Chemother Pharmacol; 1989; 25(2):95-8. PubMed ID: 2513137
[TBL] [Abstract][Full Text] [Related]
18. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
Zhou JL; Brodie A
J Steroid Biochem Mol Biol; 1995 Jan; 52(1):71-6. PubMed ID: 7857875
[TBL] [Abstract][Full Text] [Related]
19. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
